Signal Detection and Management in Pharmacovigilance

Shubham Chaudhari

Domain Consultant, TCS ADD Platforms

Achyuth Tanay Kota

Domain Consultant, TCS ADD Platforms

Ashutosh Pachisia

Data Scientist, TCS ADD Platforms

All pharmaceutical products approved to be used in a marked setting have proven benefits but are also associated with adverse effects. The detection of such unknown risks is important to ensure the safety of patients. Signal detection and management in pharmacovigilance necessitates the ongoing monitoring of individual case safety reports (ICSR) to identify case reports of adverse events (AE) that are worthy for further exploration. Traditionally, signals are detected either qualitatively or quantitatively. Qualitative detection involves a deep analysis through manual assessment of the ICSR in an individual or cumulative manner, whereas the quantitative method involves statistical techniques such as disproportionality analysis.

In this white paper series, we propose a hybrid approach where the algorithm is fueled to assess a signal and manage it for effective grading based on a qualitative approach

Shubham Chaudhari

Achyuth Tanay Kota

Ashutosh Pachisia

Contact

TCS is here to make a difference through technology.

We’re in it for good, driving positive change for the benefit of all.

Extraordinary expertise leads to remarkable results.

Want to be a global change-maker? Join our team.

Find the latest news about TCS in our Newsroom

Recent Press releases

Recent News

Recent recognitions

Upcoming events

TCS works hand in hand with world-leading investors.